Noema Pharma Appoints Dr. Ilise Lombardo as CEO to Drive Advancements in Clinical-Stage CNS Pipeline
- Jun 21, 2023
- 1 min read
Basel, Switzerland, June 21, 2023 (Globe Newswire) -- Noema Pharma, a clinical-stage biotech company targeting central nervous system disorders, welcomes Dr. Ilise Lombardo as their new Chief Executive Officer. With her extensive experience in the CNS space and a robust clinical pipeline, Dr. Lombardo is well-positioned to lead Noema in developing innovative therapies for debilitating CNS conditions and achieving key clinical milestones.
Read full article here.
Comments